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Abstract
 
Major histocompatibility complex (MHC) class I variants H-2K
 
b
 
 and H-2K
 
bm8
 
 differ primarily
in the B pocket of the peptide-binding groove, which serves to sequester the P2 secondary anchor
residue. This polymorphism determines resistance to lethal herpes simplex virus (HSV-1) infection
by modulating T cell responses to the immunodominant glycoprotein B
 
498-505
 
 epitope, HSV8.
We studied the molecular basis of these effects and confirmed that T cell receptors raised
against K
 
b
 
–HSV8 cannot recognize H-2K
 
bm8
 
–HSV8. However, substitution of Ser
 
P2
 
 to Glu
 
P2
 
(peptide H2E) reversed T cell receptor (TCR) recognition; H-2K
 
bm8
 
–H2E was recognized
whereas H-2K
 
b
 
–H2E was not. Insight into the structural basis of this discrimination was ob-
tained by determining the crystal structures of all four MHC class I molecules in complex with
bound peptide (pMHCs). Surprisingly, we find no concerted pMHC surface differences that
can explain the differential TCR recognition. However, a correlation is apparent between the
recognition data and the underlying peptide-binding groove chemistry of the B pocket, reveal-
ing that secondary anchor residues can profoundly affect TCR engagement through mecha-
nisms distinct from the alteration of the resting state conformation of the pMHC surface.
Key words: major histocompatibility complex • crystallography • antigen presentation • 
herpes simplex virus 1 • T cells
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Introduction
 
Cytotoxic CD8
 
 
 
 T cells are the main effector arm of the
adaptive immune system in charge of combating intracellular
pathogens. These cells recognize pathogen-derived peptides
presented by surface-expressed MHC class I molecules and
lyse the infected cell that bears them. Analysis of the three-
dimensional crystal structures of MHC class I molecules in
complex with bound peptide (pMHCs) has revealed in
great molecular detail the mechanisms these proteins use to
bind a vast number of chemically distinct peptides (1, 2).
The peptide-binding groove formed by the 
 
 
 
1/
 
 
 
2 domains is
structured to bind peptides 8–10 amino acids long in an
extended conformation. Eight 
 
 
 
-strands establish the plat-
form floor of the groove, with two antiparallel 
 
 
 
-helices
serving as its walls. The peptide binds between these helices
and uses its main chain and terminal atoms to form exten-
sive hydrogen bonds to MHC side chains, enabling peptide
binding in a predominantly sequence-independent manner.
Peptide selectivity is achieved via discrete peptide-binding
pockets present in the groove that are tailored to preferen-
tially accept a subset of peptide side chains dubbed binding
anchors. The high degree of polymorphism observed in
class I alleles is clustered to residues that form these binding
pockets, providing the basis for allele-specific peptide-bind-
ing motifs (3). The motifs for most MHC class I alleles can
be described as a combination of preferred residues lo-
cated at primary and secondary anchor positions (4). Primary
anchor residues are typically completely buried within the
peptide-binding groove pockets in a tightly coordinated
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shape complementarity; T
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, midpoint of thermal denaturation. 
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fashion; only a highly restricted set of amino acids can typi-
cally serve as the primary anchor of a given pocket, allow-
ing for highly stable peptide binding. In contrast, secondary
anchor residues tend to be less restrictive in allowable se-
quence due to flexibility of the engaging pocket, and their
substitution to less favorable residues often does not mark-
edly affect peptide-binding affinity or kinetics.
TCR recognition of pMHC has also been studied exten-
sively (5). The recent crystal structures of TCR–pMHC
complexes have demonstrated that the TCR binds in a
roughly diagonal orientation over the groove-flanking
 
 
 
-helices, positioning its CDR loops over the peptide (6–8).
Numerous studies examining the role of solvent-exposed,
TCR-contacting peptide side chains in TCR recognition
have shown that even minor chemical differences in them
can be discerned (9–12). In contrast, the peptide anchor side
chains are buried and are thought unable to directly contact
the TCR. These, and other similar observations, suggest that
modulation of peptide-binding affinity is the dominant way
anchor side chains affect TCR recognition. However, our
group and others have recently reexamined this issue and
have shown that peptide anchor side chains, especially sec-
ondary anchors, can have a more direct effect, independent
of peptide-binding affinity, on TCR recognition (13–15).
One of the best-studied models in which discrete varia-
tion affects one of the minor anchor pockets of an MHC
class I molecule is provided by allelic variant molecules
H-2K
 
b
 
 (K
 
b
 
) and its spontaneous mutant, H-2K
 
bm8
 
 (K
 
bm8
 
).
K
 
bm8
 
 arose from K
 
b
 
 by a gene conversion event (16) that
changed four amino acids [Tyr
 
22
 
 to Phe
 
22
 
; Met
 
23
 
 to Ile
 
23
 
;
Glu
 
24
 
 to Ser
 
24
 
; and Asp
 
30
 
 to Asn
 
30
 
] all located on the plat-
form floor of the peptide-binding groove. Of these four
residues, two (MHC 23 and 30) are thought to be largely
irrelevant to antigen processing and presentation, as their
side chains point away from the peptide-binding groove,
are not solvent accessible, and are not analogous to residues
shown previously to contact TCRs (17). The two remain-
ing residues, MHC 22 and 24, point into the groove and
serve to create the B pocket, where they contact the side
chain of the second amino acid of the bound peptide (P2).
Indeed, site-directed mutagenesis has shown that most, if
not all, of the effects of the K
 
bm8
 
 mutation upon presenta-
tion of the antigenic peptide OVA-8 can be recapitulated
by isolated mutations at MHC 22 and 24 (18). Notably, K
 
b
 
and K
 
bm8
 
 have identical sequences at their membrane distal
TCR-contacting residues. Therefore, the bulk of biological
differences between them are likely a consequence of indi-
rect effects of the changes in the B pocket, which could be
manifest as differences in peptide-binding preferences or al-
ternate conformations of identically presented peptides.
The hallmark of peptides naturally presented by K
 
b
 
 is the
presence of two primary anchors: a phenylalanine or tyro-
sine as the fifth (or sixth) residue and a leucine as the last of
eight (or nine) residues (4, 19). These two primary anchors
find themselves deeply buried in the C and F pockets of the
K
 
b
 
 peptide-binding groove, respectively, and their substitu-
tion to other amino acids typically results in a dramatic re-
duction in affinity and pMHC stability at the cell surface
(20). We have previously characterized an important sec-
ondary anchor located at the peptide P2 position that lies
sequestered in the B pocket of the K
 
b
 
 groove that, in this
allele, is directly adjacent to the C pocket (21). Interest-
ingly, the preferred residue at P2 depends on which pri-
mary anchor occupies the C pocket; Ala and Gly are
preferred if the C pocket anchor is Tyr, whereas medium-
sized residues predominate for primary Phe anchors (15,
21). Peptide elution experiments demonstrated that many
peptides ignore the K
 
bm8
 
 mutation and are able to bind to
both molecules with high stability, although a subset does
bind differentially (20, 22). Despite the discrete nature of
the change in K
 
bm8
 
, the two molecules exhibit differences
in several interrelated biological properties, including pep-
tide-dependent antibody recognition (23), cross-reactivity
(24, 25), peptide binding and presentation (11, 14, 25, 26),
and intrathymic repertoire selection (27, 28). Most impor-
tantly, the coisogeneic mouse strains C57BL/6 (B6, H-2
 
b
 
)
and B6.C-H-2
 
bm8
 
 (bm8, H-2
 
bm8
 
), which differ from each
other solely by expression of K
 
b
 
 or K
 
bm8
 
, also differ in sus-
ceptibility to HSV-1, due to the fact that the dominant
epitope of this virus, the glycoprotein B epitope 498-505
(called here HSV8), elicits a markedly more efficient CTL
response in bm8 mice (29).
Previously, we reported that B6 mice immunized with
HSV8 produce CTLs, which readily recognize K
 
b
 
–HSV8,
but are unable to recognize K
 
bm8
 
–HSV8 (14). This dif-
ference was not due to differential affinity or stability of
peptide binding, nor was it due to gross conformational
changes, as assayed by a panel of conformation-sensitive
antibodies. As the alteration in K
 
bm8
 
 potentially changes the
hydrogen bond network between the peptide P2 side chain
and the MHC B pocket, we hypothesized that this change
might somehow be manifest at the pMHC surface, where it
could be directly detected by TCR. To test this hypothesis,
we performed second-site reversion of the K
 
bm8
 
 mutation
by introducing compensatory P2 peptide mutations that
could restore the lost hydrogen bond network. Indeed,
changing the peptide Ser
 
P2
 
 to a Glu
 
P2
 
 (H2E peptide) com-
pensated for the reciprocal Glu
 
24
 
 to Ser
 
24
 
 mutation present
in K
 
bm8
 
, so that the same K
 
b
 
–HSV8-reactive TCR that
could not recognize K
 
bm8
 
–HSV8 was able to recognize
K
 
bm8
 
–H2E. However, when this H2E peptide was bound
to K
 
b
 
, there was no detectable TCR recognition. Although
our paper highlighted an important role for secondary an-
chor residues in TCR recognition, it remained unclear how
exactly these B pocket interactions were being discerned.
To resolve this issue at the atomic level, we have now
undertaken the study of these pMHCs by protein crystal-
lography, solving the crystal structures of four distinct com-
plexes: K
 
b
 
–HSV8, K
 
bm8
 
–HSV8, K
 
b
 
–H2E, and K
 
bm8
 
–H2E.
Examining the surface properties of each pMHC revealed,
to our surprise, only nonconcerted differences that do not
appear to correlate with T cell activation profiles. How-
ever, our structures did reveal localized features of the
pMHC B pockets that do correspond with our TCR rec-
ognition data. When compared with K
 
b
 
–HSV8, K
 
bm8
 
–
HSV8 and K
 
b
 
–H2E contained alternate hydrogen bonding 
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and chemical environments in their B pockets, resulting in
loss of B6-derived TCR recognition. Alternatively, K
 
bm8
 
 in
complex with the H2E peptide containing the secondary
anchor substitution resulted in a B pocket environment
closely approximating the one present in K
 
b
 
–HSV8. Thus,
our results indicate that pMHC binding pocket modifica-
tions can profoundly affect TCR activation without signif-
icantly altering the resting state (TCR unliganded) confor-
mation of the pMHC surface, demonstrating that they can
be significant determinants in an immune response.
 
Materials and Methods
 
Protein Expression and Purification.
 
The K
 
b
 
 ectodomain (1–274)
and m
 
 
 
2
 
m were expressed and purified from cell supernatants of
 
Drosophila melanogaster
 
 S2 cells using established protocols (17,
19). In brief, purification consisted of Ni
 
 
 
2
 
 chelation chromatog-
raphy followed by incubation with molar excess of either HSV8
or H2E peptides. Each peptide was synthesized using standard
protocols and tested for identity by electrospray MS. The result-
ing complexes were subjected to ion-exchange chromatography
(MonoQ) followed by size exclusion chromatography. Native gel
electrophoresis and isoelectric focusing were used to ensure the
homogeneous nature of these pMHC samples. Additionally, pre-
viously published protocols (30) for bacterial expression and sub-
sequent oxidative refolding was used to produce K
 
b
 
 (1–274) and
K
 
bm8
 
 (1–280) ectodomains in complex with m
 
 
 
2
 
m.
 
Circular Dichroism (CD) and Thermal Denaturation.
 
Experi-
ments were performed in a manner similar to what has been pub-
lished previously for other MHC class I peptide complexes (31,
32). All four bacterially expressed, oxidatively refolded pMHCs
were buffer exchanged to 0.2 mg/ml (5 
 
 
 
m) in 10 mM
KH
 
2
 
PO
 
4
 
/K
 
2
 
HPO
 
4
 
 pH 7.5, 150 mM NaCl, and 0.01% sodium
azide using Centricon filtration devices (Amicon, Inc.). Three in-
dependent thermal denaturation experiments per pMHC were
undertaken at the CD shared equipment facility at the University
of Medicine and Dentistry of New Jersey. The midpoint of ther-
mal denaturation (T
 
m
 
) for each protein was calculated by taking
the first derivative of the ellipticity data at 218 nm and identifying
the inflexion point.
 
Crystallization and Structure Determinations.
 
Purified K
 
bm8
 
 and
K
 
b
 
 peptide complexes were concentrated to 5–6 mg/ml in 20 mM
ammonium acetate, pH 6.9, and 0.01% sodium azide. Crystals of
insect cell–expressed K
 
b
 
 peptide complexes were produced in
hanging drops by vapor diffusion at 20
 
 
 
C against wells filled with
3–5% MPD, 2.0 M Na/K
 
2
 
PO
 
4
 
, pH 6.5, and molar excess HSV8
or H2E peptide. Bacterially expressed, oxidatively refolded K
 
bm8
 
peptide complex crystals were grown similarly in 12–15% PEG
8000, 100 mM sodium cacodylate, pH 6.6, and 100–150 mM cal-
cium acetate. Diffraction quality crystals appeared within 48 h and
were cryoprotected just before flash cooling through the 1:1 addi-
tion of well solution plus 20% ethylene glycol (K
 
bm8
 
) or 25% glyc-
erol (K
 
b
 
). Diffraction data for K
 
bm8
 
–H2E crystals were collected
using a Rigaku X-ray source and an R-axis IV image plate detec-
tor, while data for the other three pMHCs were obtained at the
Advanced Photon Source (APS), beamline ID-19 (SBC-CAT).
Data were indexed and processed using DENZO and SCALE-
PACK (see Table I and reference 33). K
 
b
 
 peptide complexes
crystallized in the P2
 
1
 
2
 
1
 
2 space group with one pMHC in the
asymmetric unit (ASU), whereas K
 
bm8
 
 peptide complexes crystal-
lized in the P2
 
1
 
 space group and had two pMHCs in the ASU. A
nearly isomorphous K
 
b
 
 structure, PDB ID code 1KJ3, without its
peptide and with its mutant residues truncated to alanine, was
rigid body refined into K
 
bm8
 
–HSV8 data. The HSV8 peptide was
traced and the model was built to high confidence after several it-
erative rounds of model building in O (34) coupled to atomic re-
finement and map generation with the CNS program (35). This
high confidence K
 
bm8
 
–HSV8 model was used as a starting point
for the K
 
bm8
 
–H2E model. A similar procedure was performed for
the K
 
b
 
 peptide complex structures, with PDB ID code 2VAA
used as the starting point. Each K
 
b
 
–peptide complex model con-
tained m
 
 
 
2
 
m (residues 1–99), K
 
b
 
 (residues 1–274), and the respec-
tive full-length peptide. The K
 
b
 
–HSV8 complex model contains
one N-linked carbohydrate at Asn
 
86
 
, whereas the K
 
b
 
–H2E com-
plex model contains two N-linked carbohydrates at Asn
 
86
 
 and
Asn
 
176
 
. The m
 
 
 
2m present in the Kbm8–peptide complexes con-
tained an additional NH2-terminal Met residue numbered residue
zero. Kbm8 models contained residues 1–278; poor electron density
for Ser279 and Thr280 prevented them from being modeled.
Computational Analysis. Graphical structure representations
were created using Ribbons (36). The molecular surfaces of the B
pockets were generated using sph-ms, a component program of
Ribbons, using a 1.4 Å probe. Specifically, the P2 peptide C 
and side chain atoms were removed from the structure, and
sph-ms was used to generate the dot surface of the B pocket with
the rest of the peptide bound. The geometric surface comple-
mentarity of the peptide–MHC interfaces was calculated with the
program SC (37). Electrostatic potential maps were generated with
Delphi, and Grasp was used to read in these maps and graphically
display each pMHC’s electrostatic molecular surface potential
(38). The 2C TCR from the Kb–2C complex (PDB idcode 2CKB)
was docked via the MHC  1/ 2 regions onto our pMHCs.
PDBDIST was used to determine TCR–pMHC contacts within
4.2 Å and these delineated the TCR contact box present in Fig. 2
(39). HBplus was used to determine the hydrogen bonding in
each pMHC’s B pocket (40). RMSD calculations between struc-
tures were calculated with the CNS program using pMHCs su-
perimposed via their  1/ 2 domains (35). RMSDs of mutant
residues were calculated using positionally equivalent atoms (i.e.,
side chain O  of SerP2 considered equivalent to GluP2 side chain
C ). The reference structure for these calculations was one of the
Kbm8–H2E structures (chains D and Q) in the ASU. Simulated
annealing electron density omit maps of B pocket residues for
each complex were generated using the CNS program and dis-
played in Ribbons (35, 36).
Results
pMHC Crystal Structure Determinations. We reported
previously that B6-derived T cells exhibit a restricted,
mono-specific pattern of recognition of the dominant pep-
tide epitope of the HSV-1, HSV8; this peptide was recog-
nized only when presented by Kb, but not when bound to
its variant, Kbm8 (14). At that time, we hypothesized that
this was due to the loss of hydrogen bonds between SerP2
of HSV8 and the altered B pocket of Kbm8 (particularly due
to the key mutations Tyr22 to Phe22 and Glu24 to Ser24).
We supported this hypothesis by performing second-site
reversion of TCR recognition: introduction of a glutamic
acid at position P2 of HSV8 (peptide H2E) led to reconsti-
tution of T cell recognition of the new pMHC, Kbm8–
H2E. Since then, we have confirmed these observations
using several CTL lines and clones (41).TCR Discrimination of B Pocket Variation in pMHCs 1448
In this paper, we set out to solve the crystal structures of
all four pMHCs to ascertain whether any differences exist
that could explain our differential TCR recognition. Kb–
HSV8 and Kb–H2E were expressed in D. melanogaster cells
and recovered from cell supernatants, whereas Kbm8–HSV8
and Kbm8–H2E were oxidatively refolded from Escherichia
coli inclusion bodies. The Kb–peptide complexes crystal-
lized in the primitive orthorhombic space group P21212
with one pMHC in the ASU. The Kbm8–peptide com-
plexes, which lack N-linked carbohydrate additions at resi-
dues Asn86 and Asn176, crystallized in the primitive mono-
clinic space group P21 and have two pMHCs per ASU.
Each structure was solved by molecular replacement and
after several rounds of model building and refinement,
quality atomic models were obtained (Fig. 1). Kb–HSV8
was solved to 2.6 Å resolution, whereas the Kb–H2E com-
plex was solved to 2.1 Å resolution. The estimated coordi-
nate error (Luzzati) for each complex is 0.30 and 0.25 Å,
respectively. Similarly, Kbm8–HSV8 was solved to 1.9 Å
resolution and Kbm8–H2E was solved to 2.6 Å resolution
with estimated coordinate errors of 0.27 and 0.37 Å, re-
spectively. A summary of the data collection and refine-
ment results are presented in Table I.
The structures of Kb and Kbm8 that we have resolved are
very similar to those that have been described previously
(17, 19). The HSV8 and H2E peptides bind in a canonical
fashion to both MHC molecules. The side chains of resi-
dues PheP5 and LeuP8 are deeply buried into the MHC
binding groove, serving as primary anchors and sequester-
ing into the C and F pockets, respectively. Similarly, the
Ser/GluP2 and IleP3 side chains are also buried, acting as
secondary anchors at the B and D pockets, respectively.
Pointed away from the peptide-binding groove are the side
chains of SerP1, GluP4, AlaP6, and ArgP7. Although the SerP1
side chain is solvent inaccessible due to its small size, the
other three side chains have significant solvent exposure.
These observations are consistent with studies that demon-
strate P4, P6, and P7 residues of HSV8 are major TCR de-
terminants, with larger substitutions at P1 also perturbing
TCR recognition (11, 14, 23).
Comparison of pMHC Surface Properties. It has been
shown previously that small but significant differences in
pMHC surface properties can occur between peptides pre-
sented by Kb and its natural occurring variants (17). SEV9
and VSV8 peptides in complex with Kbm1 have a notably
different electrostatic surface compared with analogous Kb
complexes, whereas the Kbm8 complexes were very similar
to those of Kb. We initiated a structural analysis of our
pMHCs to determine if any significant differences could be
identified. The electrostatic surface properties of each
pMHC were calculated using Delphi and visualized using
GRASP. This analysis reveals the potential TCR interact-
ing surface of each pMHC to be virtually indistinguishable
from one another, with the exception of the surface sur-
rounding the ArgP7 peptide residue (Fig. 2). The signifi-
cance of this difference is likely minimal as it is due to alter-
nate crystal contacts that, in Kb, are positioned over the
COOH terminus of the peptide. This results in a different
conformation of the ArgP7 side chain as well as a small local
rearrangement that is centered around Ser73. It is unlikely
that this rearrangement plays a significant role in TCR rec-
ognition, as the conformation of ArgP7 is nearly isostructural
between respective recognized and unrecognized pMHC
structures (i.e., Kbm8–H2E vs. Kbm8–HSV8).
Figure 1. Crystallographic electron density maps of the pMHC B
pockets. Sigma-weighted simulated annealing Fo-Fc omit electron density
maps contoured at 3.5  around the B pocket regions of all four pMHCs.
(cyan) Kb and Kbm8 carbon; (yellow) HSV8 and H2E peptide carbon;
(red) oxygen; (blue) nitrogen; (orange) water. Recognized pMHCs are in
green boxes and unrecognized pMHCs are in red boxes.
Figure 2. pMHC electrostatic surface properties. The membrane-distal,
peptide-binding platforms of all four pMHCs are depicted. Electrostatic
properties were mapped to the molecular surfaces using the program
GRASP. Surface colors are contoured from red ( 8kT) to blue ( 8kT).
Elements of the surface corresponding to the peptides are approximately
enclosed with dashed lines. (solid lines) The portion of the pMHC surface
containing modeled 2C TCR contacts is boxed.Miley et al. 1449
Next, we undertook a comparative analysis of the pMHC
structures to ascertain whether there is any correlative struc-
ture variation. Analysis of  1/ 2 domain similarity revealed
an RMSD deviation of  0.8 Å between the four Kbm8  1/
 2 domains, whereas RMSD deviation between the two Kb
 1/ 2 domains was 0.45 Å. However, the RMSD deviation
between the Kb structures and Kbm8–H2E complex was  1.2 Å
(Table I). These differences in global  1/ 2 structure can be
largely attributed to differences in loop conformations and, in
the case of Kb to Kbm8 comparisons, differences in crystal
packing and solvent conditions. Specifically, loops between  
strands 1/2, 3/4, and 5/6 were highly divergent, even be-
tween both molecules in the ASU of the Kbm8 structures.
Differential crystal packing at the  -strand 4/helix 1 region
(MHC 52–57) in the Kbm8 structures results in another area of
significant conformational difference. These regions are not
known to have any influence on conventional TCR recogni-
tion. Further inspection of MHC residues did not reveal
other residues with significant, correlated deviations that
could potentially make direct contact with the TCR.
Comparison of the four peptides from these pMHCs
demonstrates that small, but significant, positional differ-
ences occur at the amino terminal ends of the peptides.
When the peptides are superimposed, via the respective
MHC  1/ 2 domains, these differences become clear (Fig.
3). Remarkably, the largest of these structural differences
occurs between the two complexes, Kb–HSV8 and Kbm8–
H2E (Fig. 3, green), which are recognized equivalently.
Seen from a top-down perspective, the most noticeable de-
viations occur at the P1 and P2 positions, highlighting a lat-
eral displacement of these residues (Fig. 3 A). In contrast,
the two unrecognized complexes, Kb–H2E and Kbm8–
HSV8 (Fig. 3, red), are fairly similar in conformation to the
Kbm8–H2E peptide structure. A side view perspective re-
veals an additional downward shift of the SerP2 in Kb–HSV8
from the GluP2 of Kbm8–H2E (Fig. 3 B). This displacement
is propagated through the peptide main chain, causing a di-
minishing shift through P3 and a prominent movement of
P1. The P3–P8 residues, common to all peptides, are nearly
isostructural between Kb and Kbm8 structures, with the ex-
Table I. Summary of Data Collection, Phasing, and Refinement
Data collection for H-2Kb and H2-Kbm8 peptide complexes
Data set Kbm8–H2E Kbm8–HSV8 Kb–H2E Kb–HSV8
Space group P21 P21212
Unit cell (abc, Å;    ,  ) a = 66.57; b = 90.18;
c = 88.98;   = 111.32;
 ,  = 90
a = 66.56; b = 90.13;
c = 89.01;   = 111.39;
 ,  = 90
a = 135.24; b = 89.54;
c = 45.25;  , ,  = 90
a = 134.89; b = 90.22;
c = 45.45;  , ,  = 90
Wavelength (Å) 1.5418 1.0332 0.97945
X-ray source Rigaku APS-19-ID APS-19-ID APS-19-ID
Resolution, outer shell (Å) 20-2.6 (2.7-2.6) 20-1.9 (1.97-1.9) 20-2.1 (2.17-2.1) 20-2.6 (2.69-2.6)
Observations/unique 70,233/29,043 411,580/72,537 229,268/32,839 79,892/17,348
Completeness (%) 95.6 (93.5) 94.0 (77.7) 99.9 (100) 99.1 (99.9)
Rsym (%) 10.2 (42.1) 7.6 (36.0) 7.0 (35.4) 9.1 (36.9)
I/  8.8 (1.8) 19.9 (3.1) 27.3 (5.2) 15.0 (3.9)
Refinement statistics
Molecules in ASU 2 2 1 1
Rcrystal, outer shell (%) 23.0 (38.9) 22.9 (33.5) 20.7 (24.2) 19.8 (26.5)
Rfree, outer shell (%) 28.7 (43.1) 25.7 (35.4) 23.1 (27.1) 23.9 (35.1)
Avg. temperature factor (Å2) 36.0 35.0 32.8 35.0
Rms deviations
Bonds (Å), angles ( ) 0.007/1.33 0.005/1.29 0.005/1.30 0.006/1.30
Coordinate error estimates
Luzzati, SigmaA 0.37/0.49 0.27/0.31 0.25/0.16 0.30/0.23
Ramachandran plot
Favored, allow., gener. (%) 85.4/13.7/1.0 91.7/7.7/0.6 89.1/10.3/0.6 90.9/8.5/0.6
PDB ID code 1RJZ 1RJY 1RK1 1RK0
Structural analysis
 1/ 2/peptide RMSD (Å) –/0.72 0.75/0.92 1.23 1.20
Peptide SC 0.71/0.68 0.71/0.72 0.72 0.70TCR Discrimination of B Pocket Variation in pMHCs 1450
ception of the P7 side chain conformer difference, which is
due to differential crystal packing between Kb and Kbm8.
When these positional deviations were quantitated, we
found that only the peptide amino terminal variations of
Kb–HSV8 and Kbm8–H2E (Fig. 3 C, green bars) were signif-
icant, albeit small. Their displacements were two to three
times larger than those observed between Kbm8–H2E and its
replicate in the ASU (Fig. 3 C, black bars), a measure of ex-
perimental error. However, these results are in stark contrast
with the TCR recognition data, as the magnitude of the
positional deviation does not correlate to recognition. To-
gether, it is clear that TCR recognition in this system does
not correlate to evident surface properties of the pMHCs,
indicating that the TCR may well be discriminating be-
tween other biophysical properties of the complexes.
Comparison of Kb and Kbm8 B Pocket Environments. Kb
and Kbm8 differ in two residues, MHC 22 and MHC 24,
which serve to create B pockets that are unique to each
molecule. A comparison of the B pockets from each of our
pMHCs demonstrates that the bm8 mutations increase the
size and alter the chemical environment, allowing for dif-
ferent peptide-binding modes (Fig. 4). The B pockets in
the Kb–peptide complexes are elongated, but shallow, due
mainly to residue Glu24 that sits directly underneath the P2
anchor (Fig. 5). The Kb B pocket accommodates HSV8
very well, with the SerP2 directly interacting with Glu24. In
contrast, the GluP2 mutation in the H2E peptide is forced
into an unfavorable chemical environment. This GluP2 side
chain is too large to occupy the space where Wat2 is lo-
cated in the Kb–HSV8 structure; its accommodation would
require rearrangement of several Kb B pocket side chains.
Additionally, that conformation would put the negatively
charged GluP2 in very close proximity to the negatively
charged Glu24 side chain, creating an unfavorable electro-
static interaction given that peptide loading occurs at near
neutral pH. Instead, the GluP2 side chain turns away from
Glu24 and tucks itself underneath the main chain of the
peptide. Surprisingly, the H2E peptide provides a similar
“fit” for the Kb binding groove as the HSV8 peptide, as as-
sessed by comparable shape complementarity (SC) coeffi-
cients (Table I and reference 37).
The B pockets of the Kbm8–peptide complexes are signifi-
cantly altered compared with their Kb counterparts; the bm8
mutations allow the pocket to become much deeper and
more neutral. A secondary effect of these mutations is the
rearrangement of the Tyr45 side chain, causing a widening
and further deepening of the pocket. This rearrangement is
similar to the ones observed in other Kbm8 peptide structures
(17). Accommodation of SerP2 by Kbm8 is very similar to
what is observed in the Kb–HSV8 complex. However, the
Figure 3. Positional deviation analysis of MHC presented
peptides. Peptides from all four pMHCs have been superim-
posed via their  1/ 2 domains. They are shown from a top-
down perspective (A) and a side view (B). (green) Peptides
from recognized pMHCs. (red) Peptides from unrecognized
pMHCs. The large difference observed for ArgP7 is due to alter-
nate crystal packing arising from different space groups. (C) The
positional differences of the peptides were quantitated and
graphed to denote per residue main and side chain differences
in reference to Kbm8–H2E. Recognized peptides (green) and
unrecognized peptides (red) have been compared with one of
the peptides from the Kbm8–H2E crystal structure (chain Q of
1RJZ), with the differences between the two peptides in the
Kbm8–H2E ASU (black) representing a measure of experimen-
tal error.Miley et al. 1451
SerP2 rides higher in the Kbm8 B pocket than in the Kb B
pocket (Fig. 4). This results in a shifting of Wat2 to allow for
favorable interactions between SerP2 and pocket residues,
and for the inclusion of an additional water, Wat4, behind it.
In contrast with the Kb–H2E complex, the larger, and no
longer negatively charged Kbm8 B pocket allows the GluP2
side chain to extend in an alternate conformation similar to
the SerP2 side chains in the other complexes (Fig. 4). This
extension displaces Wat2 and allows the GluP2 side chain to
directly interact with Tyr45. Despite the differences in the
peptide-binding grooves of Kb and Kbm8, and the B pocket
in particular, the fit of both peptides is quantitatively similar,
with SC coefficients ranging from 0.68 to 0.72 (Table I).
Comparison of pMHC Thermostability. The rearrange-
ments we have observed for the peptide P2 and MHC B
pocket residues could potentially alter the stability of the
respective pMHC and, thus, may explain our differential
TCR recognition. Indeed, the sevenfold difference in ther-
mostability observed for SEV9 and VSV8 peptides presented
by Kb and Kbm1 has been implicated in their differential
TCR recognition profiles (17). To address this issue, we
measured the thermostability of each pMHC using CD. All
pMHCs had Tm values  37 C, further supporting the ob-
servation that they are all stable under physiological condi-
tions (Fig. 6). Reproducibly higher Tm values were observed
for HSV8 complexes ( 49 C) when compared with those
of the H2E complexes ( 44 C). Thus, the thermal stability
of Kb and Kbm8 is dependent on which peptide is loaded, and
the measured stability is in no way correlated with T cell
recognition. Consistent with our CD experiments are previ-
ously reported data concerning the cell surface stability of
our pMHCs on living cells as measured by conformation-
sensitive antibodies (11, 14) and T cell–based assays (29).
Comparison of B Pocket Hydrogen-bonding Networks. The
diversity of our pMHCs and their TCR recognition does
not seem to correlate with their apparent resting state sur-
face properties, as resolved crystallographically, or with their
relative cell surface and in vitro stabilities. However, this is
not the case when the B pocket environment is examined.
Analysis of B pocket hydrogen-bonding networks and
chemical environments for the four pMHCs reveals an ap-
Figure 4. Surface representation of pMHC B pockets. The Tyr22 to
Phe22, and Glu24 to Ser24 mutations present in Kbm8 relative to Kb result in
a larger, more accommodating, and neutral B pocket. Residues are repre-
sented as CPK models. Peptide atoms are in grayscale. (Yellow) P2 side
chain carbon; (cyan) MHC carbon; (red) MHC oxygen; (orange) waters.
The molecular surfaces of the B pockets are represented with purple dots.
Figure 5. pMHC B pocket hydrogen bonding schemes. The B pocket
hydrogen bonding networks of all four pMHCs are depicted. The specific
interactions of peptide P2 residues with MHC are highlighted. Recog-
nized pMHCs are in green boxes and the unrecognized pMHCs are in
red boxes. (cyan) MHC carbon atoms; (yellow) peptide carbon; (red) oxy-
gen; (blue) nitrogen; (orange) water. Potential hydrogen bonds are depicted
as small purple spheres.
Figure 6. pMHC thermostability as measured by CD. CD ellipticity
data at 218 nm corresponding to the first melting transition was normal-
ized to a scale of 0 to 1. The Tm for each pMHC is noted in the legend.
All pMHCs experienced a second transition at higher temperatures with a
corresponding Tm of  69 C, which we interpret as the unfolding of
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parent correlation with T cell recognition profiles (Fig. 5).
In the TCR-recognized Kb–HSV8 complex, SerP2 forms
two distinct hydrogen bonds: one to Glu24 at the base of the
pocket and another to Wat2, which mediates a linkage to
Glu63. In contrast, this same peptide in complex with Kbm8
has an altered hydrogen-bonding pattern and distinct B
pocket chemical environment. Specifically, the Glu24 to
Ser24 bm8 mutation makes the pocket more neutral and
causes Tyr45 to reposition to establish a water-mediated hy-
drogen bond with SerP2 of HSV8. Additionally, the reposi-
tioning of Wat2 allows Glu63 to hydrogen bond with the P2
main chain nitrogen. Although these B pocket alterations
are small, they are clearly significant enough that the Kbm8–
HSV8 complex does not activate Kb–HSV8-reactive T cells.
TCR recognition of Kbm8 presenting the dominant
HSV-1 epitope is regained with the introduction of a com-
pensating peptide mutation at the P2 secondary anchor
position, SerP2 to GluP2. The resulting H2E peptide, in
complex with Kbm8, is able to faithfully mimic the hydro-
gen-bonding network observed in the Kb–HSV8 complex
(Fig. 5). The GluP2 side chain extends to displace Wat2 and
place its carboxylate group in a position similar to the car-
boxylate of Glu24 in Kb. This similar positioning allows for
both restoration of the pocket’s negative charge and estab-
lishment of a hydrogen-bonding pattern analogous to Glu24
in Kb. However, TCR recognition is again lost when the
H2E peptide is in complex with Kb. GluP2 assumes an alter-
nate conformation, likely due to charge repulsion from
Glu24, causing disruption of hydrogen bonding between
Glu24 and Asn70; this allows Wat2 back into the pocket, and
introduces a new hydrogen bond between its carboxylate
and the P3 main chain nitrogen. This hydrogen bond com-
plements part of its negative charge, likely helping to stabi-
lize the Kb–H2E complex.
Thus, the results of our structural analysis would indicate
that the designed peptide variant H2E is able to successfully
form a similar packing geometry and chemistry of the B
pocket when bound to Kbm8 as is otherwise formed only
when HSV8 is complexed with Kb. In contrast, significant
alterations to the B pocket hydrogen-bonding network are
readily apparent in the other two pMHCs that fail to be
recognized by Kb–HSV8-reactive T cells.
Discussion
In this paper, we have examined four distinct pMHCs
whose sequence variations are localized to residues located
in the B pocket of the peptide-binding groove. Our goal
was to understand how a compensating mutation in a sec-
ondary anchor position of a dominant HSV-1 peptide was
able to restore recognition by Kb-restricted, HSV-1–reac-
tive T cells when in complex with an allelic variant of Kb,
Kbm8. Thus, the second-site revertant Kbm8–H2E, like Kb–
HSV8, elicits activating responses in T cell effector assays,
whereas Kb–H2E and Kbm8–HSV8 do not. We have shown
previously that neither impaired peptide binding nor pre-
sentation can explain this differential pMHC recognition
(14). Our current results establish that the loading of HSV8
onto either Kb or Kbm8 results in pMHCs with similar ther-
mal stabilities as measured by CD, whereas the loading of
our designed H2E peptide results in systematically less ther-
mally stable complexes.
Next, we turned to crystallography to elucidate struc-
tural details that may provide further insight into our func-
tional observations. The crystal structures of all four pMHCs
were determined and, as expected, the P2 residues of both
HSV8 and H2E are sequestered from solvent in the B
pocket, proximal to the allelic variant residues Tyr22/Phe22
and Glu24/Ser24. To our surprise, comparison of the TCR-
unliganded structures did not reveal any concerted struc-
tural differences localized to the membrane-distal surfaces
of the pMHCs otherwise considered important in TCR
engagement. Furthermore, the small conformational differ-
ences of solvent-accessible residues observed in our work
did not appear to correlate with the available TCR recog-
nition data. However, comparison of the manner in which
the P2 secondary anchor residue is engaged in the B pocket
of the pMHCs revealed that the two recognized complexes
have similar packing structures, whereas the B pocket in-
teractions of the ignored complexes are distinct. We will
now turn to considerations of how these results might be
important for the TCR recognition process.
Peptide Anchor Residues and Their Role in the Immune Re-
sponse. There have been many studies directed at exam-
ining TCR–pMHC recognition, many of which have
revolved around the role of solvent-exposed/TCR-con-
tacting peptide residues. Using many different MHC class I
and II systems, it has been shown that TCRs can be ex-
tremely sensitive to even conservative mutations at these
solvent-exposed residues (9–11). These results have been
supported by the growing number of TCR–pMHC com-
plex structures available (6–8). It is clear from these struc-
tures that a limited number of solvent-exposed peptide res-
idues interact extensively with CDR loops of the TCR,
and that peptide anchor residues and their surrounding
MHC environments are not major recognition determi-
nants. Although anchor residues can unquestionably impact
TCR recognition indirectly by modulating MHC binding
affinity and selection, other mechanisms of action have
been proposed (15, 42–44).
Our current results are similar to a paper we published
several years ago in a class II model (13). We have shown
that for I-Ek/Hb, a minor change in the peptide P6 second-
ary anchor residue results in both a distinct, nonoverlapping
bulk T cell population as well as a 1,000-fold difference in
specific T cell activation. Structure determination of these
pMHCs revealed minor structural differences in solvent-
exposed atoms and an altered hydrogen-bonding network
in the P6 pocket. Similarly, our Kb/Kbm8 data demonstrate
that perturbations of buried residues can have a significant
impact on T cell repertoire generation, selection, and speci-
ficity. Indeed, although functional stability of Kb–Kbm8–HSV8
complexes was indistinguishable as measured by both Ab-
based (14) and T cell–based assays (29), T cell repertoire se-
lection in the thymus, T cell diversity mobilized in response
to HSV-1 infection, and T cell–mediated resistance to lethalMiley et al. 1453
HSV-1 infection were all heavily impacted by the alter-
ations in the B pocket of the aforementioned complexes
(28, 29, 41). The majority of previous TCR recognition
studies have focused on the dominant role solvent-accessible
pMHC residues can play in T cell activation processes. Our
results extend these studies and demonstrate that buried
peptide and MHC pocket residues can also be significant
determinants in an immune response. Thus, our data further
highlight the exquisite structural sensitivity that governs
pMHC recognition by TCRs.
Potential Impact of B Pocket Environment on TCR Recogni-
tion. Analysis of our structural data reveals that the bm8
substitutions of B pocket residues and their interactions do
not translate into significant positional changes in solvent-
exposed residues. Furthermore, the small changes that we
did observe failed to correlate with T cell activation data.
Nevertheless, our differential T cell recognition data dem-
onstrate that, even though on the surface they appear
chemically similar, the various pMHCs are readily discrim-
inated. Thus, it is apparent that the B pocket environment
is modulating one or more properties on which TCR rec-
ognition and subsequent T cell activation is dependent.
One possible discriminatory mechanism could be that our
B pocket mutations affect the way in which the pMHC is
engaged by the TCR. The available structural data for
TCR–pMHC complexes indicate that there is a significant
amount of structural flexibility in the TCR, notably in the
CDR3 loops, with less structural variation observed in
pMHC residues upon complex formation (7, 8). Neverthe-
less, a recent set of structures has demonstrated that near-
identical pMHCs, Kb/dEV8 and Kbm3/dEV8, result in two
very distinct structures when in complex with a common
TCR, 2C (45). The difference between the two pMHCs is
a buried Asp77 to Ser77 mutation that is associated with a dif-
ferential hydrogen-bonding pattern with the peptide. Spe-
cifically, the bm3 mutation is associated with altered presen-
tation of the dEV8 peptide as well as an increase in overall
TCR–pMHC contact and SC. Thus, an extremely minor
change in hydrogen bonding and chemical environment
can have substantial effects on the way a TCR engages
nearly isostructural resting state pMHCs. In accordance
with this data, we postulate that both our allelic and second-
ary anchor mutations need not be in direct contact with
TCR to elicit profound changes in recognition. For exam-
ple, one could speculate that the ability of Kb-restricted,
HSV-1–reactive T cells to engage only Kb–HSV8 and
Kbm8–H2E is a manifestation of each pMHC’s unique ability
to adopt a conformation consistent with stable complex for-
mation, or alternatively the transition state energy barrier to
achieve a stable complex is too high for the unrecognized
pMHCs (46). However, irrespective of the discriminatory
mechanism, our data clearly support the notion that MHC
anchor pocket environments can be just as significant an an-
tigenic determinant as solvent-exposed peptide side chains.
Given that some of the most pronounced effects of the Kb/
Kbm8 polymorphism exert themselves at the level of in-
trathymic positive selection of TCR repertoire (27, 28), it is
likely that this environment can play a broad role, affecting
all the biological consequences of the TCR–pMHC con-
tact. Moreover, this also implies that the self-peptides that
mediate differential positive selection of TCR when pre-
sented by either Kb or Kbm8 must themselves participate in
analogous, variable B pocket interactions as does the domi-
nant HSV-1 epitope, providing another level of similarity
between antigenic and positively selecting peptides.
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